We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Manufacturers of Key Drugs Need Emergency Plans, Guidance Says
Manufacturers of Key Drugs Need Emergency Plans, Guidance Says
February 2, 2010
Drugmakers that are the sole or primary source for certain key drugs need to be able to continue production during a pandemic and should create emergency production plans that can delay or modify some GMPs to ensure production, a draft guidance says.